Striatal oxidative damage parallels the expression of a neurological phenotype in mice transgenic for the mutation of Huntington's disease

Brain Research

Volumn 862, Issue 1-2, 2000, Pages 234-237

  Pérez Severiano, Francisca ^a,b   Ríos, Camilo ^b   Segovia, José ^a  

^a Departamento de Fisiología   (Mexico)

^b NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

Author keywords

Huntington's disease; Lipid peroxidation; Motor behavior; Oxidative damage; Striatum; Transgenic mice

Indexed keywords

FREE RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN INJURY; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; GENE MUTATION; HUNTINGTON CHOREA; LIPID PEROXIDATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; TRANSGENIC MOUSE;

EID: 0342635463     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02082-5     Document Type: Article

References (17)

1. Beal M.F. Mitochondrial dysfunction in neurodegenerative disease. Biochim. Biophys. Acta. 1366:1998;211-223.
2. Browne S.E., Ferrante R.J., Beal M.F. Oxidative stress in Huntington's disease. Brain Pathol. 9:1999;147-163.
3. Carter R.J., Lione L.A., Humby T., Mangiarini L., Mahal A., Bates G.P., Dunnett S.B., Morton A.J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 19:1999;3248-3257.
4. Dunnett S.B., Carter R.J., Watts C., Torres E.M., Mahal A., Mangiarini L., Bates G., Morton A.J. Striatal transplantation in a transgenic mouse model of Huntington's disease. Exp. Neurol. 154:1998;31-40.
5. Gutteridge J.M., Halliwell B. The measurement and mechanism of lipid peroxidation in biological systems. Trends Biochem. Sci. 15:1990;129-135.
6. Hansson O., Petersén Å., Leist M., Nicotera P., Castilho R.F., Brundin P. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proc. Natl. Acad. Sci. USA. 96:1999;8727-8732.
7. Harper P.S. Huntington's Disease. 1991;1-15 Saunders, London.
8. Hurlbert M.S., Zhou W., Wasmeier C., Kaddis F.G., Hutton J.C., Freed C.R. Mice transgenic for an expanded CAG repeat in the Huntington's disease gene develop diabetes. Diabetes. 48:1999;649-651.
9. Lione L.A., Carter R.J., Hunt M.J., Bates G.P., Morton J.A., Dunnett S.B. Selective discrimination learning impairments in mice expressing the human Huntington's disease mutation. J. Neurosci. 19:1999;10428-10437.
10. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., Lawton M., Trottier Y., Lehrach H., Davies S.W., Bates G.P. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 87:1996;493-506.
11. Pérez-Severiano F., Escalante B., Ríos C. Nitric oxide synthase inhibition prevents acute quinolate-induced striatal neurotoxicity. Neurochem. Res. 23:1998;1297-1302.
12. Petersén Å., Mani K., Brundin P. Recent advances on the pathogenesis of Huntington's disease. Exp. Neurol. 157:1999;1-18.
13. Polidori M.C., Mecocci P., Browne S.E., Senin U., Beal M.F. Oxidative damage to mitochondrial DNA in Huntington's disease parietal cortex. Neurosci. Lett. 272:1999;53-56.
14. Reddy P.H., Williams M., Charles V., Garrett L., Pike-Buchannan L., Whetsell W.O., Miller G., Tagle D.A. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing a mutated full-length HD cDNA. Nat. Genet. 20:1998;198-202.
15. Schapira A.H.V. Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia. Biochim. Biophys. Acta. 1410:1999;159-170.
16. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell. 72:1993;971-983.
17. ++ injection. J. Neurochem. 42:1984;976-979.